Healios KK
TSE:4593

Watchlist Manager

Healios KK

TSE:4593

Watchlist

Dividends

Discount Rate

Price: 171 JPY -5.52% Market Closed

Market Cap: 15.4B JPY

Have any thoughts about
Healios KK?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

Add Price Alert

Price Target:

Last Price: 171 JPY

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

Alert

Healios KK

171

-10 (-5.52%)

52 Week Range	115 259
Price Target

We'll email you a reminder when the closing price reaches JPY.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Healios KK

What unique competitive advantages
does Healios KK hold over its rivals?

What risks and challenges
does Healios KK face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Healios KK.

What unique competitive advantages
does Healios KK hold over its rivals?

What risks and challenges
does Healios KK face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Healios KK.

Provide P/S
for Healios KK.

Provide P/E
for Healios KK.

Provide P/OCF
for Healios KK.

Provide P/FCFE
for Healios KK.

Provide P/B
for Healios KK.

Provide EV/S
for Healios KK.

Provide EV/GP
for Healios KK.

Provide EV/EBITDA
for Healios KK.

Provide EV/EBIT
for Healios KK.

Provide EV/OCF
for Healios KK.

Provide EV/FCFF
for Healios KK.

Provide EV/IC
for Healios KK.

Show me price targets
for Healios KK made by professional analysts.

What are the Revenue projections
for Healios KK?

How accurate were the past Revenue estimates
for Healios KK?

What are the Net Income projections
for Healios KK?

How accurate were the past Net Income estimates
for Healios KK?

What are the EPS projections
for Healios KK?

How accurate were the past EPS estimates
for Healios KK?

What are the EBIT projections
for Healios KK?

How accurate were the past EBIT estimates
for Healios KK?

Compare the revenue forecasts
for Healios KK with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Healios KK and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Healios KK against its competitors.

Analyze the profit margins
(gross, operating, and net) of Healios KK compared to its peers.

Compare the P/E ratios
of Healios KK against its peers.

Discuss the investment returns and shareholder value creation
comparing Healios KK with its peers.

Analyze the financial leverage
of Healios KK compared to its main competitors.

Show all profitability ratios
for Healios KK.

Provide ROE
for Healios KK.

Provide ROA
for Healios KK.

Provide ROIC
for Healios KK.

Provide ROCE
for Healios KK.

Provide Gross Margin
for Healios KK.

Provide Operating Margin
for Healios KK.

Provide Net Margin
for Healios KK.

Provide FCF Margin
for Healios KK.

Show all solvency ratios
for Healios KK.

Provide D/E Ratio
for Healios KK.

Provide D/A Ratio
for Healios KK.

Provide Interest Coverage Ratio
for Healios KK.

Provide Altman Z-Score Ratio
for Healios KK.

Provide Quick Ratio
for Healios KK.

Provide Current Ratio
for Healios KK.

Provide Cash Ratio
for Healios KK.

What is the historical Revenue growth
over the last 5 years for Healios KK?

What is the historical Net Income growth
over the last 5 years for Healios KK?

What is the current Free Cash Flow
of Healios KK?

Discuss the annual earnings per share (EPS)
trend over the past five years for Healios KK.

Section:

Wall Street
Price Targets

Price Targets Summary
Healios KK

Wall Street analysts forecast Healios KK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Healios KK is 374 JPY with a low forecast of 323.2 JPY and a high forecast of 420 JPY.

Lowest

Price Target

323.2 JPY

89% Upside

Average

Price Target

374 JPY

119% Upside

Highest

Price Target

420 JPY

146% Upside

Healios KK Competitors:
Price Targets

UTHR

United Therapeutics Corp

12% Upside

688687

Beijing Kawin Technology Share-holding Co Ltd

67% Upside

300896

Imeik Technology Development Co Ltd

39% Upside

MIRM

Mirum Pharmaceuticals Inc

54% Upside

UTHR

United Therapeutics Corp

12% Upside

688687

Beijing Kawin Technology Share-holding Co Ltd

67% Upside

300896

Imeik Technology Development Co Ltd

39% Upside

MIRM

Mirum Pharmaceuticals Inc

54% Upside

603392

Beijing Wantai Biological Pharmacy Enterprise Co Ltd

15% Downside

068270

Celltrion Inc

30% Upside

ANIK

Anika Therapeutics Inc

66% Upside

NBIX

Neurocrine Biosciences Inc

23% Upside

Revenue
Forecast

Revenue Estimate
Healios KK

For the last 8 years the compound annual growth rate for Healios KK's revenue is 3%. The projected CAGR for the next 3 years is 133%.

Past Growth

133%

Estimated Growth

Estimates Accuracy

17%

Average Beat

What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Healios KK

Operating Income forecast
is not available for
Healios KK

Net Income
Forecast

Net Income Estimate
Healios KK

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-34%

Average Miss

What are analyst estimates?

What is Healios KK's stock price target?

Price Target
374 JPY

According to Wall Street analysts, the average 1-year price target for Healios KK is 374 JPY with a low forecast of 323.2 JPY and a high forecast of 420 JPY.

What is Healios KK's Revenue forecast?

Projected CAGR
133%

For the last 8 years the compound annual growth rate for Healios KK's revenue is 3%. The projected CAGR for the next 3 years is 133%.

	Franklin Covey Co NYSE:FC	36.41 USD -1.03%
	Mohawk Industries Inc NYSE:MHK	119.16 USD 2%
	Ardmore Shipping Corp NYSE:ASC	11.31 USD 0.18%
	ASGN Inc NYSE:ASGN	83.87 USD -0.97%
	Skyworks Solutions Inc NASDAQ:SWKS	88.75 USD 0.56%
	Weatherford International PLC NASDAQ:WFRD	67.1 USD -2.13%

	Johnson & Johnson NYSE:JNJ	144.47 USD 0.62%
	Bank of America Corp NYSE:BAC	44.17 USD 1.82%
	Mastercard Inc NYSE:MA	528.03 USD 0.91%
	Salesforce Inc NYSE:CRM	343.65 USD 2.21%
	Abbvie Inc NYSE:ABBV	175.58 USD 2.37%
	Home Depot Inc NYSE:HD	392.6 USD 1.97%

	Arista Networks Inc NYSE:ANET	112.81 USD 3.43%
	Visa Inc NYSE:V	317.71 USD 0.9%
	Texas Pacific Land Corp NYSE:TPL	1 133.12 USD 3.36%
	KLA Corp NASDAQ:KLAC	629.37 USD 1.16%
	Manhattan Associates Inc NASDAQ:MANH	280.26 USD -0.81%
	Pinduoduo Inc NASDAQ:PDD	99.51 USD -1.48%

	Salesforce Inc NYSE:CRM	343.65 USD 2.21%
	Accenture PLC NYSE:ACN	366.37 USD -1.56%
	ServiceNow Inc NYSE:NOW	1 091.25 USD 1.52%
	EOG Resources Inc NYSE:EOG	119.04 USD 0.69%
	Copart Inc NASDAQ:CPRT	58.22 USD -0.39%
	Applied Materials Inc NASDAQ:AMAT	163.59 USD 1.33%

Healios KK
TSE:4593